MedPath

A Combinatorial Biomarker for Infection Diagnosis in Children

Recruiting
Conditions
Respiratory Tract Infections
Fever
Interventions
Diagnostic Test: BV
Registration Number
NCT05971901
Lead Sponsor
Universität des Saarlandes
Brief Summary

To describe the epidemiology, clinical presentation, diagnosis, therapy, and treatment outcomes of patients in whom the combination biomarker BV (combination of TRAIL, IP-10, and CRP) is used, and to compare them with control patients without BV measurement.

Secondary objectives:

* Qualitative evaluation of indication as well as adherence to the test result.

* Comparison of antimicrobial therapy, performed diagnostics, hospitalization, and outcomes between patients with high BV score (bacterial) and patients with low BV score (viral).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
770
Inclusion Criteria
  • Suspicion of acute bacterial or viral infection
  • Requirement of at least one BV test during medical presentation
Exclusion Criteria
  • lack of informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
BV use casesBVcases in whom BV was ordered
Primary Outcome Measures
NameTimeMethod
Antibioticsup to 30 days

Number of participants treated with antibiotics

Secondary Outcome Measures
NameTimeMethod
Hospitalizationup to 30 days

Number of participants admitted to the hospital

Antibiotic durationup to 30 days

Length of antibiotic treatment per participant

Complicationsup to 30 days

Rate of complications per participant

Testsup to 30 days

Rate of ancillary tests per participant

Trial Locations

Locations (4)

Saarland University

🇩🇪

Homburg, Germany

Universitätsklinikum Bonn

🇩🇪

Bonn, Germany

Sana Kliniken

🇩🇪

Berlin, Germany

Universitätsklinikum Würzburg

🇩🇪

Würzburg, Germany

© Copyright 2025. All Rights Reserved by MedPath